You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dalfampridine

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Boston (drug, behavioral, other)

Not yet recruiting
  • Multiple Sclerosis
  • Dalfampridine 10 MG [Ampyra]
  • +2 more
  • Boston, Massachusetts
    MGH Institute of Health Professions
Nov 13, 2023

Multiple Sclerosis Trial (Dalfampridine Pill, Placebo)

Completed
  • Multiple Sclerosis
  • Dalfampridine Pill
  • Placebo
  • (no location specified)
May 5, 2023

Multiple Sclerosis Trial in Cairo (Dalfampridine ER, 10 Mg Oral Tablet, Extended Release, Placebo)

Recruiting
  • Multiple Sclerosis
  • Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
  • Placebo
  • Cairo, Egypt
    Ain Shams Univeristy
Feb 15, 2023

Hereditary Spastic Paraplegia Trial in Nicosia (Dalfampridine 10 MG, Placebo, Physiotherapy)

Completed
  • Hereditary Spastic Paraplegia
  • Dalfampridine 10 MG
  • +2 more
  • Nicosia, Cyprus
    Dr. Burhan Nalbantoğlu State Hospital
Nov 17, 2022

Motor Neuron Disease, Upper Trial in Gainesville, Boston, New York (dalfampridine)

Active, not recruiting
  • Motor Neuron Disease, Upper
  • dalfampridine
  • Gainesville, Florida
  • +2 more
Mar 29, 2022

Spinal Cord Injury Trial in Chicago (drug, other, behavioral)

Recruiting
  • Spinal Cord Injury
  • Dalfampridine
  • +3 more
  • Chicago, Illinois
    Shirley Ryan Abilitylab
Jul 6, 2022

Nerve Injury Trial in Hershey (4-Aminopyridine, Placebo oral tablet)

Terminated
Has Results
  • Nerve Injury
  • Hershey, Pennsylvania
    MS Hershey Medical Center
Oct 12, 2022

Multiple Sclerosis Trial in Buffalo (dalfampridine, )

Completed
Has Results
  • Multiple Sclerosis
  • dalfampridine
  • placebo
  • Buffalo, New York
    Buffalo General Hospital
Sep 29, 2020

Multiple Sclerosis, Optic Neuritis Trial in Saint Louis (Dalfampridine/Placebo, Placebo/Dalfampridine)

Completed
Has Results
  • Multiple Sclerosis
  • Optic Neuritis
  • Dalfampridine/Placebo
  • Placebo/Dalfampridine
  • Saint Louis, Missouri
    Washington University (John L. Trotter MS Center)
Jan 23, 2020

Multiple Sclerosis, Internuclear Ophthalmoplegia, Fatigue Trial in Cleveland (Dalfampridine, Placebo)

Completed
Has Results
  • Multiple Sclerosis
  • +2 more
  • Dalfampridine
  • Placebo
  • Cleveland, Ohio
    Louis Stokes VA Medical Center, Cleveland, OH
Sep 1, 2020

Multiple Sclerosis Trial in Kirkland (dalfampridine ER, )

Completed
Has Results
  • Multiple Sclerosis
  • dalfampridine ER
  • placebo
  • Kirkland, Washington
    MS Center at Evergreen
Oct 3, 2018

Post-ischemic Stroke Trial in Canada, United States (dalfampridine-ER 7.5 mg, dalfampridine-ER 10 mg)

Terminated
Has Results
  • Post-ischemic Stroke
  • dalfampridine-ER 7.5 mg
  • dalfampridine-ER 10 mg
  • Gilbert, Arizona
  • +65 more
Jan 17, 2019

Transverse Myelitis, Neuromyelitis Optica, Idiopathic Transverse Myelitis Trial in Baltimore (Dalfampridine, Placebo)

Completed
Has Results
  • Transverse Myelitis
  • +3 more
  • Dalfampridine
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins University
Mar 14, 2018

Multiple Sclerosis Trial in Odense C (Fampridine)

Completed
  • Multiple Sclerosis
  • Odense C, Denmark
    University of Southern Denmark - Odense Univarsity Hospital
Mar 31, 2022

Central and Peripheral Nervous System Changes as Markers of

Completed
  • Multiple Sclerosis
  • +7 more
    • Sønderborg, Jylland, Denmark
      Department of Neurology (Skleroseklinikken), Sygehus Sønderjylla
    Oct 13, 2021

    Walking Impairment, Multiple Sclerosis Trial in Canada, United States (ADS-5102, 137 mg, ADS-5102, 274 mg, Placebo)

    Completed
    Has Results
    • Walking Impairment
    • Multiple Sclerosis
    • ADS-5102, 137 mg
    • +2 more
    • Cullman, Alabama
    • +83 more
    Dec 19, 2021

    Spinal Cord Injury Trial in West Orange (Dalfampridine, Placebo)

    Completed
    • Spinal Cord Injury
    • Dalfampridine
    • Placebo
    • West Orange, New Jersey
      Kessler Institute for Rehabilitation
    Nov 29, 2017

    Post-Ischemic Stroke Trial in Canada, United States (Placebo, dalfampridine-ER 7.5mg, dalfampridine-ER 10mg)

    Completed
    Has Results
    • Post-Ischemic Stroke
    • Placebo
    • +2 more
    • Gilbert, Arizona
    • +73 more
    Jun 4, 2018

    Episodic Ataxia Type 2 Trial in Los Angeles, Tampa, Rochester (4-Aminopyridine, Placebo)

    Withdrawn
    • Episodic Ataxia Type 2
    • Los Angeles, California
    • +2 more
    Nov 12, 2020

    Multiple Sclerosis Trial in Besancon (Fampridine)

    Completed
    • Multiple Sclerosis
    • Besancon, France
      CHU Jean Minjoz
    Jan 29, 2021

    Sleep Apnea, Obstructive Trial in Boston (Placebo, Dalfampridine)

    Completed
    Has Results
    • Sleep Apnea, Obstructive
    • Placebo
    • Dalfampridine
    • Boston, Massachusetts
      Sleep Disorders Research Program Brigham and Women's Hospital
    Jul 14, 2017

    to Document Drug Utilization of Fampyra When Used In Routine

    Completed
    • Multiple Sclerosis
    • Ciudad Autonoma de Buanos Aires, Buenos Aires, Argentina
    • +167 more
    Jun 4, 2019

    Multiple Sclerosis Trial in Mexico City (4-aminopyridine, Placebo)

    Completed
    Has Results
    • Multiple Sclerosis
    • Mexico City, Distrito Federal, Mexico
      Hospital de Especialidades, CMN Siglo XXI
    Aug 6, 2019

    Multiple Sclerosis Trial in Denmark (SR-fampridine, Placebo)

    Completed
    • Multiple Sclerosis
    • Esbjerg, Denmark
    • +3 more
    Aug 22, 2018

    Multiple Sclerosis Trial in Denmark (Fampridine-SR)

    Completed
    • Multiple Sclerosis
    • Esbjerg, Denmark
    • +3 more
    Aug 22, 2018